Authored by Karl Simpson
Stockholm based Karolinska Development has announced the appointment of Christian Tange as their new Chief Financial Officer, replacing Robin Wright who will leave the company at the end of the month to fulfil a new role in the UK. Tange will bring to the role of CFO over 15 years experience in international growth companies. For a sustained period, 2003-1012, he served as CFO for CMC Biologics, a global biotech CMO. He holds a Masters degree in Economics and Law from Copenhagen business School. He will begin his CFO role with Karolinska Development from March 1st 2014.
Karolinska Development has also announced the appointment of Bernd R. Seizinger to the board of portfolio company Aprea AB. Dr. Seizinger is Chariman of Opsona Therapeutics, a Dublin based start-up headed by Martin Welschof. Opsona is an orphan drug company looking at therapies in oncology and transplantation. Dr. Bernd R. Seizinger was also formerly Vice President, Oncology Drug Discovery at BMS. Aprea AB is a Swedish company developing cancer therapies targeting the tumour suppressor protein p53.